NCT07592728 · George Mason University
Brief Inhibitory Training for Eating - Intervention
(BITE-I)
What this study is about
The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training. Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life. Aim 2 is to evaluate the effectiveness of IC training for modifying the hypothesized intervention mechanism: food-related IC and eating regulation.
View original scientific description
The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training. Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life. Aim 2 is to evaluate the efficacy of IC training for modifying the hypothesized intervention mechanism: food-related IC and eating regulation.
Interventions
BEHAVIORAL
Daily inhibitory control training
Children will first complete a short nutrition education then complete daily 10-minute inhibitroy control training each day for 10 minutes across 3 weeks
Primary outcome measures
Inhibitory control
Time frame: 1 month
Go-No/Go Task with food cues
Eating self-regulation
Time frame: 1 month
Self-Regulation of Eating Behaviour Questionnaire
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- 14-17 years old
- Have overweight or obesity (BMI-z≥85th percentile)
- Have a smartphone
- Can read and speak English
- Interest in improving one's diet.
Exclusion criteria
- Not currently in eating disorder or weight loss treatment or receiving pharmacological/surgical treatment for obesity in the past four weeks
- Not meeting criteria for atypical anorexia nervosa or bulimia nervosa
Where
- Fairfax, Virginia
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 17, 2026 · Source of record for eligibility and locations